Tazolent 1.125 Injection
Marketer
Digilent Pharmaceuticals Private Limited
Salt Composition
Piperacillin (1000mg) + Tazobactum (125mg)
Overview Tazolent 1.125 Injection
Tazolen 1.125 Injection combines two antibiotics to combat diverse bacterial infections by eliminating microorganisms. Administered solely by medical professionals, self-injection is strictly prohibited. Dosage and frequency are determined by your physician based on illness severity; adhere precisely to prescribed instructions. Common side effects may include nausea, vomiting, diarrhea, and skin rash; injection site reactions such as pain, swelling, or redness are also possible. Persistent or worsening side effects necessitate immediate medical consultation. Prior to treatment, disclose any antibiotic allergies, kidney, or liver issues to your doctor; this may necessitate dosage adjustment or alternative medication. Under medical guidance, this injection is generally considered safe for use during pregnancy and breastfeeding.
Uses of Tazolent 1.125 Injection
Infections caused by bacteria
Major Benefits of Tazolent 1.125 Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Tazolent 1.125 Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Tazolent 1.125 Injection:
Administering this medication will be performed by your healthcare provider. Self-medication is strictly prohibited.
How Tazolent 1.125 Injection works:
Tazolent 1.125 Injection unites Piperacillin, an antibiotic, with Tazobactum, a beta-lactamase inhibitor. Piperacillin's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Tazobactum counters bacterial resistance, thereby optimizing Piperacillin's antibacterial effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from using Tazolent 1.125 Injection concurrently with alcohol consumption.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Tazolent 1.125 Injection is typically regarded as safe. Preclinical trials in animals revealed minimal or absent harm to offspring; nonetheless, clinical data from human subjects are scarce.
Breast feedingSAFE IF PRESCRIBED
Ceftazidime 1.125 gram injection poses minimal breastfeeding risk. Research in humans indicates negligible drug transfer to breast milk, presenting no appreciable harm to infants.
DrivingCONSULT YOUR DOCTOR
The effect of Tazolent 1.125 Injection on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with kidney impairment should use Tazolent 1.125 Injection judiciously, as dose modification may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Tazolent 1.125 Injection in individuals with hepatic impairment appears to present a low risk. Existing evidence indicates dose modification may be unnecessary; however, medical advice is recommended.
What if you forget to take Tazolent 1.125 Injection :
Should you inadvertently omit a scheduled dose of Tazolent 1.125 Injection, seek immediate medical advice.
Facts to Know About Tazolent 1.125 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobials |


